More retirement-age Americans, most infant boomers, are working today than ever previously, but it’s not …
Read More »Arcturus Therapeutics Has Begun A Phase 1/2 Study On Its Covid-19 Vaccine Candidate
Arcturus Therapies ARCT -16.4% revealed today that it has initiated dosing of its Covid-19 vaccine candidate– LUNAR COV-19, (ARCT-021)– in a Stage 1/2 study in cooperation with Duke-NUS hospital in Singapore. So, Arcturus remains in the video game. The friend of runners in the race to a Covid-19 vaccine consists …
Read More »